Literature DB >> 23667362

Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes.

Natalie Grizenko1, Ricardo M Rodrigues Pereira, Ridha Joober.   

Abstract

OBJECTIVE: To assess the sensitivity of scales (Conners' Global Index Parent and Teacher form [CGI-P, CGI-T], Clinical Global Impression Scale [CGI], Continuous Performance Test [CPT], and Restricted Academic Situation Scale [RASS]) in evaluating improvement in symptomatology with methylphenidate in different Attention Deficit Hyperactivity Disorder (ADHD) subtypes.
METHOD: Four hundred and ninety children (309 with ADHD Combined/Hyperactive [ADHD-CH] and 181 with ADHD Inattentive subtype [ADHD-I]) participated in a two week double-blind placebo-controlled crossover methylphenidate trial.
RESULTS: CGI-P showed small effect size for ADHD-I and medium effect size for the ADHD-CH subtype. CGI-T showed medium effect size for ADHD-I and large effect size for ADHD-CH subtype. CGI and RASS showed large effect size while CPT showed medium effect size for both subtypes.
CONCLUSION: Acute behavioural assessments by clinicians (CGI, RASS) are better at detecting improvement with medication in all subtypes than parent or teacher reports (CGI-P, CGI-T). CGI-T is better than CGI-P for ADHD-I in detecting change in symptomatology as there is a greater demand for attention at school.

Entities:  

Keywords:  ADHD; ADHD subtypes; Attention Deficit Hyperactivity Disorder; CGI; CPT; Conners’ scales; RASS; hyperactivity; inattention; scales

Year:  2013        PMID: 23667362      PMCID: PMC3647632     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  16 in total

1.  NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.

Authors:  D Shaffer; P Fisher; C P Lucas; M K Dulcan; M E Schwab-Stone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

2.  Differentiating between ADHD sub-types on CCPT measures of sustained attention and vigilance.

Authors:  Jens Egeland; Susanne Nordby Johansen; Torill Ueland
Journal:  Scand J Psychol       Date:  2009-03-25

3.  Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

4.  Independent dimensions of hyperactivity and aggression: a validation with playroom observation data.

Authors:  R Milich; J Loney; S Landau
Journal:  J Abnorm Psychol       Date:  1982-06

5.  Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder.

Authors:  J Sprafkin; K D Gadow
Journal:  J Child Adolesc Psychopharmacol       Date:  1996       Impact factor: 2.576

Review 6.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

7.  A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Authors:  Laurence L Greenhill; Robert L Findling; James M Swanson
Journal:  Pediatrics       Date:  2002-03       Impact factor: 7.124

8.  The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

9.  Is the inattentive subtype of ADHD different from the combined/hyperactive subtype?

Authors:  Natalie Grizenko; Michael Paci; Ridha Joober
Journal:  J Atten Disord       Date:  2009-09-18       Impact factor: 3.256

10.  Use of the restricted academic task in ADHD dose-response relationships.

Authors:  M Fischer; R F Newby
Journal:  J Learn Disabil       Date:  1998 Nov-Dec
View more
  5 in total

1.  A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.

Authors:  Daniel Y Lin; Christopher J Kratochvil; Wen Xu; Ling Jin; Deborah N D'Souza; William Kielbasa; Albert J Allen
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05       Impact factor: 2.576

Review 2.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

3.  Sensory subtypes in children with autism spectrum disorder: latent profile transition analysis using a national survey of sensory features.

Authors:  Karla K Ausderau; Melissa Furlong; John Sideris; John Bulluck; Lauren M Little; Linda R Watson; Brian A Boyd; Aysenil Belger; Virginia A Dickie; Grace T Baranek
Journal:  J Child Psychol Psychiatry       Date:  2014-03-27       Impact factor: 8.982

Review 4.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

5.  Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.

Authors:  Katharine Pillidge; Ashley J Porter; Jared W Young; S Clare Stanford
Journal:  J Psychopharmacol       Date:  2016-04-19       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.